Weil is advising Churchill Capital Corp VII (Churchill VII), a special purpose acquisition company, in its definitive agreement for a business combination with CorpAcq Holdings Limited (CorpAcq), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses. The transaction values CorpAcq at a pro forma enterprise value of approximately $1.58 billion.

Churchill Capital invests in, executes value-enhancement strategies for and provides other support for high-quality, entrepreneurial businesses in the public markets. Upon closing of the transaction, the combined company will operate as CorpAcq and intends to list on the New York Stock Exchange.

Michael Klein, Chairman and CEO of Churchill VII, said, "When we launched Churchill VII, we wanted to identify a profitable, cash flow generating partner with strong management, a highly differentiated business model and clear growth opportunities. We believe CorpAcq fits all our criteria and more with its proven acquisition and operating strategy, established positioning in the UK SME space, track record of topline growth and profitability and talented management team."

The Weil team was led by Mergers & Acquisitions partner Michael J. Aiello and includes Mergers & Acquisitions partners Matthew Gilroy and Amanda Fenster, Mergers & Acquisitions counsel Claudia Lai and Iliana Karaoglan and Mergers & Acquisitions associates Andrew Sunol, Julia Sichun Liu and Olga Cosme Toledo. The team also includes Capital Markets Head Alexander Lynch;  Capital Markets partner Barbra Broudy; Capital Markets associates Paul Heller and Julia Welch; Tax Head Joseph Pari; and International Tax Head Devon Bodoh. The London team included Corporate partners David Avery-Gee and Sarah Flaherty; Corporate senior consultant Ian Hamilton; Tax partner Jenny Doak; Tax counsel Kevin Donegan; and Tax associates Enda Kerin and Grant Solomon.